Tonix Pharmaceuticals Secures Major Medicare Coverage Agreement for TONMYA
BERKELEY HEIGHTS, N.J., July 13, 2026 Tonix Pharmaceuticals announced a major managed Medicare payer agreement that will expand pharmacy...
Advertisement
Voyager Shares Positive Six-Month Alzheimer’s Data
LEXINGTON, Mass., July 13, 2026 Voyager Therapeutics presented new six-month good laboratory practice (GLP) toxicology data demonstrating that its...
Aethlon Medical Reports Encouraging Hemopurifier Trial Results
SAN DIEGO, California, July 13, 2026 Aethlon Medical, Inc. has announced encouraging interim findings from the second patient cohort...
Keenova Publishes New Real-World Acthar Gel Autoimmune Data
DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...
Q32 Bio Reports Positive Phase 2a Alopecia Trial Results
WALTHAM, Mass., July 13, 2026 Q32 Bio has announced positive 36-week topline results from Part B of the Phase...
NeuroTherapia Reports Promising Phase 2a Alzheimer’s Data
CLEVELAND, Ohio, July 13, 2026 NeuroTherapia, Inc. has announced encouraging findings from its Phase 2a clinical trial evaluating NTRX-07,...
VERAXA Partners with Ardigen on AI Cancer Discovery
ZURICH, Switzerland, July 13, 2026 VERAXA Biotech announced a strategic collaboration with AI-driven computational biology company Ardigen to accelerate...
Ocugen Signs OCU400 Licensing Agreement with Roots Pharma
MALVERN, Pa., July 13, 2026 Ocugen announced the signing of a binding term sheet with Roots Pharmaceutical and its...
PharmatrophiX Reports Positive LM11A-31 Alzheimer’s Results
MENLO PARK, California, July 13, 2026 PharmatrophiX, in collaboration with Indiana University School of Medicine, has presented encouraging new...
Longeveron Reports Positive Phase 2a Laromestrocel Data
MIAMI, July 13, 2026 Longeveron announced new analyses from its Phase 2a CLEAR MIND clinical trial demonstrating that its...
Advertisement
